Drug Information

Drug General Information
Drug ID
D00BND
Former ID
DIB015529
Drug Name
BF-1
Drug Type
Small molecular drug
Indication Migraine; Cluster headaches [ICD9: 339.00, 339.01, 339.02, 346; ICD10:G43, G44.0] Phase 1 [543126]
Company
Biofrontera
Formula
C22H25NO2S
InChI
InChI=1S/C22H25NO2S/c1-4-25-16-8-9-17-20(14-16)26-19-7-5-6-18(24-3)22(19)21(17)15-10-12-23(2)13-11-15/h5-9,14H,4,10-13H2,1-3H3
InChIKey
ANZVBVKYXOGOQC-UHFFFAOYSA-N
PubChem Compound ID
10287037
PubChem Substance ID
15292993, 22662747, 35559032, 75016602, 85228317, 139157694, 163278949, 230400138, 242882436, 246687830, 252166634
Target and Pathway
Target(s) 5-hydroxytryptamine receptor Target Info Modulator [551202]
References
Ref 543126(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8424).
Ref 551202Serotonin (5-HT2B) receptor. SciBX 4(19); doi:10.1038/scibx.2011.534. May 12 2011

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.